Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ZYIL1 Following Oral Administration in Healthy Volunteers
Clinical trial NCT04731324 · COMPLETED
Trial details
- NCT number
- NCT04731324
- Sponsor
- Zydus Lifesciences Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-28
- Primary completion
- 2021-06-12
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.